You can buy or sell EIGR and other stocks, options, ETFs, and crypto commission-free!
Eiger BioPharmaceuticals, Inc. Common Stock, also called Eiger BioPharmaceuticals, is a clinical-stage biopharmaceutical company. Read More It focuses on the development and commercialization of well-characterized drugs for life-threatening, rare and ultra-rare diseases with high unmet medical needs and no approved therapies. The company was founded by David A. Cory on November 6, 2008 and is headquartered in Palo Alto, CA.
Palo Alto, California
52 Week High
52 Week Low
Expected Nov 8, Pre-Market